Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -466 | 4,701 | 6,536 | 2,041 | 1,313 |
| Depreciation Amortization | 358 | 1,640 | 1,246 | 848 | 449 |
| Income taxes - deferred | N/A | -181 | N/A | N/A | N/A |
| Accounts receivable | 1,759 | -1,436 | -5,936 | -664 | 565 |
| Accounts payable and accrued liabilities | 411 | -1,749 | -1,135 | -947 | -565 |
| Other Working Capital | 199 | -621 | -8,348 | -3,431 | -1,927 |
| Other Operating Activity | -1,661 | 5,032 | 8,155 | 2,181 | 476 |
| Operating Cash Flow | $600 | $7,386 | $518 | $28 | $311 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -46 | -389 | -136 | -94 | N/A |
| Investing Cash Flow | $-46 | $-389 | $-136 | $-94 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -38 | -150 | -112 | -74 | -37 |
| Common Stock Issued | 24 | 320 | 314 | 276 | N/A |
| Financing Cash Flow | $-14 | $170 | $202 | $202 | $-37 |
| Beginning Cash Position | 9,785 | 2,618 | 2,618 | 2,618 | 2,618 |
| End Cash Position | 10,325 | 9,785 | 3,202 | 2,754 | 2,892 |
| Net Cash Flow | $540 | $7,167 | $584 | $136 | $274 |
| Free Cash Flow | |||||
| Operating Cash Flow | 600 | 7,386 | 518 | 28 | 311 |
| Capital Expenditure | -46 | -389 | -136 | -94 | N/A |
| Free Cash Flow | 554 | 6,997 | 382 | -66 | 311 |